Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10488 | 993 | 42.9 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1045 | 9625 | BOWMAN BIRK INHIBITOR//PROTEASE ACTIVATED RECEPTOR//CYCLOTIDES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NETHERTON SYNDROME | Author keyword | 79 | 87% | 4% | 39 |
2 | KALLIKREINS | Author keyword | 64 | 55% | 8% | 80 |
3 | KALLIKREIN RELATED PEPTIDASES | Author keyword | 54 | 83% | 3% | 30 |
4 | HUMAN KALLIKREIN 6 | Author keyword | 48 | 100% | 2% | 17 |
5 | SPINK5 | Author keyword | 40 | 79% | 3% | 26 |
6 | NEUROPSIN | Author keyword | 34 | 79% | 2% | 22 |
7 | KLK10 | Author keyword | 30 | 100% | 1% | 12 |
8 | KLK6 | Author keyword | 29 | 88% | 1% | 14 |
9 | LEKTI | Author keyword | 25 | 77% | 2% | 17 |
10 | HUMAN KALLIKREINS | Author keyword | 23 | 74% | 2% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NETHERTON SYNDROME | 79 | 87% | 4% | 39 | Search NETHERTON+SYNDROME | Search NETHERTON+SYNDROME |
2 | KALLIKREINS | 64 | 55% | 8% | 80 | Search KALLIKREINS | Search KALLIKREINS |
3 | KALLIKREIN RELATED PEPTIDASES | 54 | 83% | 3% | 30 | Search KALLIKREIN+RELATED+PEPTIDASES | Search KALLIKREIN+RELATED+PEPTIDASES |
4 | HUMAN KALLIKREIN 6 | 48 | 100% | 2% | 17 | Search HUMAN+KALLIKREIN+6 | Search HUMAN+KALLIKREIN+6 |
5 | SPINK5 | 40 | 79% | 3% | 26 | Search SPINK5 | Search SPINK5 |
6 | NEUROPSIN | 34 | 79% | 2% | 22 | Search NEUROPSIN | Search NEUROPSIN |
7 | KLK10 | 30 | 100% | 1% | 12 | Search KLK10 | Search KLK10 |
8 | KLK6 | 29 | 88% | 1% | 14 | Search KLK6 | Search KLK6 |
9 | LEKTI | 25 | 77% | 2% | 17 | Search LEKTI | Search LEKTI |
10 | HUMAN KALLIKREINS | 23 | 74% | 2% | 17 | Search HUMAN+KALLIKREINS | Search HUMAN+KALLIKREINS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUMAN TISSUE KALLIKREINS | 240 | 76% | 17% | 167 |
2 | ZYME PROTEASE M NEUROSIN | 167 | 95% | 6% | 56 |
3 | CORNEUM CHYMOTRYPTIC ENZYME | 149 | 71% | 12% | 121 |
4 | DESQUAMATION | 50 | 45% | 9% | 85 |
5 | SPINK5 | 50 | 77% | 3% | 34 |
6 | NETHERTON SYNDROME | 45 | 39% | 9% | 91 |
7 | MYELENCEPHALON SPECIFIC PROTEASE | 41 | 87% | 2% | 20 |
8 | LEKTI | 40 | 69% | 3% | 34 |
9 | HUMAN GLANDULAR KALLIKREIN | 25 | 28% | 8% | 76 |
10 | KLK5 EXPRESSION | 24 | 91% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Unleashing the therapeutic potential of human kallikrein-related serine proteases | 2015 | 2 | 214 | 53% |
Netherton syndrome: skin inflammation and allergy by loss of protease inhibition | 2013 | 29 | 69 | 94% |
The emerging roles of human tissue kallikreins in cancer | 2004 | 358 | 183 | 48% |
Functional Roles of Human Kallikrein-related Peptidases | 2009 | 74 | 53 | 72% |
Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers | 2012 | 20 | 155 | 73% |
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance | 2012 | 20 | 180 | 66% |
Human tissue kallikreins: The cancer biomarker family | 2007 | 72 | 157 | 69% |
Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers | 2008 | 52 | 37 | 62% |
Kallikrein-related peptidases | 2008 | 63 | 162 | 52% |
Order and disorder in corneocyte adhesion | 2011 | 22 | 74 | 59% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | G P ANICOLAOU ONCOL | 11 | 52% | 1.5% | 15 |
2 | HORMONE DEPENDENT CANC PROGRAM | 7 | 50% | 1.0% | 10 |
3 | STRUCT CELL BIOL | 6 | 18% | 3.2% | 32 |
4 | VIERTEL CANC | 4 | 67% | 0.4% | 4 |
5 | MOL CANC EPIDEMIOL GRP | 4 | 75% | 0.3% | 3 |
6 | PUBL HLTH CLIN MED DERMATOL VENEREOL | 4 | 46% | 0.6% | 6 |
7 | KLIN FOR ERGRP FRAUENKLIN | 3 | 50% | 0.5% | 5 |
8 | MAURIZIANO UMBERTO HOSP | 3 | 60% | 0.3% | 3 |
9 | IMMUNOL INFLAMMAT UNIT | 2 | 67% | 0.2% | 2 |
10 | PROGRAM MOL NEUROSCI | 2 | 19% | 0.9% | 9 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000122648 | PROSTATE SPECIFIC ANTIGEN//FREE PSA//FREE PROSTATE SPECIFIC ANTIGEN |
2 | 0.0000112290 | BCL2L12//BCL2 FAMILY//G P ANICOLAOU ONCOL |
3 | 0.0000103846 | MATRIPTASE//HAI 1//HEPSIN |
4 | 0.0000097386 | SJOGREN LARSSON SYNDROME//HARLEQUIN ICHTHYOSIS//LAMELLAR ICHTHYOSIS |
5 | 0.0000084381 | KALLIKREIN//KALLISTATIN//RENAL KALLIKREIN KININ SYSTEM |
6 | 0.0000071276 | NEUROSERPIN//PROTEASE NEXIN 1//PN 1 |
7 | 0.0000061926 | HAIRLESS GENE//ATRICHIA//MONILETHRIX |
8 | 0.0000061522 | STRATUM CORNEUM//TRANSEPIDERMAL WATER LOSS//CERAMIDES |
9 | 0.0000054660 | ATOPIC DERMATITIS//FILAGGRIN//ATOPIC MARCH |
10 | 0.0000053906 | DESMOSOMES//PLAKOPHILIN//PININ |